July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Detection of the angiofibrotic switch in neovascular AMD: A quantitative analysis
Author Affiliations & Notes
  • Philipp Ken Roberts
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
  • Stefan Zotter
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Alessio Montuoro
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
  • Michael Pircher
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Bernhard Baumann
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Stefan Sacu
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
  • Christoph K Hitzenberger
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Ursula Schmidt-Erfurth
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
  • Footnotes
    Commercial Relationships   Philipp Roberts, Canon Inc. (F); Stefan Zotter, Canon Inc. (F); Alessio Montuoro, None; Michael Pircher, Canon Inc. (F); Bernhard Baumann, Canon Inc. (F); Stefan Sacu, None; Christoph Hitzenberger, Canon Inc. (F); Ursula Schmidt-Erfurth, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2622. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Philipp Ken Roberts, Stefan Zotter, Alessio Montuoro, Michael Pircher, Bernhard Baumann, Stefan Sacu, Christoph K Hitzenberger, Ursula Schmidt-Erfurth; Detection of the angiofibrotic switch in neovascular AMD: A quantitative analysis. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2622.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To quantify volumetric changes of subretinal hyperreflective material (SHRM) towards subretinal fibrosis and determine the angiofibrotic switch under anti-VEGF therapy.

Methods : Patients with treatment-naïve nAMD were included in this prospective observational study. The diagnosis was made based on clinical examination, spectral-domain optical coherence tomography (SD-OCT) and fluorescein angiography (FA). Patients were imaged at baseline and after 3 months (after treatment with 3 intravitreal anti-VEGF injections) using a polarization-sensitive OCT (PS-OCT) system with a scanning angle of 30x30° and a scan pattern of 250x1024 A-scans. The device is capable of automatically detecting fibrosis and the retinal pigment epithelium (RPE) based on their birefringent and depolarizing properties, respectively. The change of the volume of SHRM over time was quantified by manual delineation in each PS-OCT B-scan and the occurrence of fibrosis was detected based on tissue birefringence.

Results : 50 eyes of 49 patients were included in the study, 28 of which had SHRM and 3 had some degree of subretinal fibrosis at baseline. In seven of these eyes subretinal fibrosis was detected at 3 months, 6 of which could be unambiguously detected based on PS-OCT imaging. All of these eyes demonstrated non-fibrotic SHRM at baseline, which converted to subretinal fibrosis until month 3. The volume, area and maximum thickness of SHRM decreased significantly from baseline to month 3 (p<0.01) and SHRM regressed completely in 7 eyes without developing fibrosis.

Conclusions : SHRM volume decreases significantly during anti-VEGF therapy, however, the conversion to subretinal fibrosis occurs in a subset of eyes as early as during the first three months of anti-VEGF treatment and can be detected by PS-OCT imaging.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×